Evaluation of the Anti‐Adhesive Effect of Milk Fat Globule Membrane Glycoproteins on Helicobacter pylori in the Human NCI‐N87 Cell Line and C57BL/6 Mouse Model

Background:  The interest in non‐antibiotic therapies for Helicobacter pylori infections in man has considerably grown because increasing numbers of antibiotic‐resistant strains are being reported. Intervention at the stage of bacterial attachment to the gastric mucosa could be an approach to improve the control/eradication rate of this infection.

[1]  O. O. Kurdaş,et al.  Supplementing Vitamins C and E to standard triple therapy for the eradication of Helicobacter pylori , 2012, Journal of clinical pharmacy and therapeutics.

[2]  Li Chen,et al.  Therapeutic efficacy of oral immunization with attenuated Salmonella typhimurium expressing Helicobacter pylori CagA, VacA and UreB fusion proteins in mice model. , 2011, Vaccine.

[3]  C. Hassan,et al.  Worldwide H. pylori antibiotic resistance: a systematic review. , 2010, Journal of gastrointestinal and liver diseases : JGLD.

[4]  J. Wu,et al.  Helicobacter pylori colonization of the human gastric epithelium: A bug's first step is a novel target for us , 2010, Journal of gastroenterology and hepatology.

[5]  S. Suerbaum,et al.  Helicobacter pylori infection , 2013, Nature Reviews Disease Primers.

[6]  M. McGuckin,et al.  MUC1 Limits Helicobacter pylori Infection both by Steric Hindrance and by Acting as a Releasable Decoy , 2009, PLoS pathogens.

[7]  K. Dewettinck,et al.  Effect of washing conditions on the recovery of milk fat globule membrane proteins during the isolation of milk fat globule membrane from milk. , 2009, Journal of dairy science.

[8]  H. Huynh,et al.  Lactoferrin and desferrioxamine are ineffective in the treatment of Helicobacter pylori infection and may enhance H. pylori growth and gastric inflammation in mice , 2009, Letters in applied microbiology.

[9]  W. Verstraete,et al.  In vitro model to study the modulation of the mucin-adhered bacterial community , 2009, Applied Microbiology and Biotechnology.

[10]  T. Hibi,et al.  Early Helicobacter pylori Eradication Restores Sonic Hedgehog Expression in the Gastric Mucosa of Mongolian Gerbils , 2009, Digestion.

[11]  Yin Li,et al.  Strain-specific inhibition of Helicobacter pylori by Lactobacillus salivarius and other lactobacilli. , 2008, The Journal of antimicrobial chemotherapy.

[12]  G. Armstrong,et al.  Prebiotic Galactooligosaccharides Reduce Adherence of Enteropathogenic Escherichia coli to Tissue Culture Cells , 2006, Infection and Immunity.

[13]  K. Dewettinck,et al.  Microfiltration of butter serum upon casein micelle destabilization. , 2006, Journal of dairy science.

[14]  D. Weerasekera,et al.  Bactericidal and anti-adhesive properties of culinary and medicinal plants against Helicobacter pylori. , 2005, World journal of gastroenterology.

[15]  R. B. de Oliveira,et al.  Non-antibiotic therapies for Helicobacter pylori infection , 2005, European journal of gastroenterology & hepatology.

[16]  T. Azuma,et al.  Identification of Helicobacter pylori and the cagA genotype in gastric biopsies using highly sensitive real-time PCR as a new diagnostic tool. , 2005, FEMS immunology and medical microbiology.

[17]  T. W. Keenan,et al.  Intracellular origin and secretion of milk fat globules. , 2005, European journal of cell biology.

[18]  Z. Samra,et al.  Susceptibility of Helicobacter pylori isolates to the antiadhesion activity of a high-molecular-weight constituent of cranberry. , 2004, Diagnostic microbiology and infectious disease.

[19]  M. Chung,et al.  Inhibition of Helicobacter pylori adhesion to human gastric adenocarcinoma epithelial cells by acidic polysaccharides from Artemisia capillaris and Panax ginseng. , 2004, Planta medica.

[20]  N. Sharon,et al.  Anti-adhesion therapy of bacterial diseases: prospects and problems. , 2003, FEMS immunology and medical microbiology.

[21]  A. M. Roberton,et al.  Antibacterial actions of fatty acids and monoglycerides against Helicobacter pylori. , 2003, FEMS immunology and medical microbiology.

[22]  T. Monath,et al.  Safety and efficacy of low dose Escherichia coli enterotoxin adjuvant for urease based oral immunisation against Helicobacter pylori in healthy volunteers , 2002, Gut.

[23]  R. Willén,et al.  Inhibition of Helicobacter pylori infection by bovine milk glycoconjugates in a BAlb/cA mouse model. , 2001, Journal of medical microbiology.

[24]  D. Blake,et al.  Antibacterial properties of xanthine oxidase in human milk , 2000, The Lancet.

[25]  I H Mather,et al.  A review and proposed nomenclature for major proteins of the milk-fat globule membrane. , 2000, Journal of dairy science.

[26]  Y. Koga,et al.  The therapeutic effect of bovine lactoferrin in the host infected with Helicobacter pylori. , 1999, Scandinavian journal of gastroenterology.

[27]  D. Zopf,et al.  Treatment of Helicobacter pylori infection in rhesus monkeys using a novel antiadhesion compound. , 1998, Gastroenterology.

[28]  M F Dixon,et al.  A standardized mouse model of Helicobacter pylori infection: introducing the Sydney strain. , 1997, Gastroenterology.

[29]  R. Jensen,et al.  Characteristics of cell lines established from human gastric carcinoma. , 1990, Cancer research.

[30]  J. Rasmussen.  Bioactivity of milk fat globule membrane proteins. , 2009 .

[31]  Samir N. Patel,et al.  Methods for antimicrobial dilution and disk susceptibility testing of infrequently isolated or fastidious bacteria; approved guideline , 2006 .

[32]  L. Hammarström,et al.  Carbohydrate-dependent inhibition of Helicobacter pylori colonization using porcine milk. , 2006, Glycobiology.

[33]  Y. Benno,et al.  Exfoliation of Helicobacter pylori from gastric mucin by glycopolypeptides from buttermilk. , 2005, Journal of dairy science.

[34]  K. Yamauchi,et al.  Bovine lactoferrin is effective to suppress Helicobacter pylori colonization in the human stomach: a randomized, double-blind, placebo-controlled study , 2005, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.